Resources
Plasmid Files

pF1A T7

Flexi® vector with an ampicillin resistance marker, for bacterial or in vitro expression of an untagged protein.

To see this sequence with restriction sites, features, and translations, please download
 SnapGene or the free  SnapGene Viewer.

pF1A T7.dna
Map and Sequence File:    Download    Open   
Sequence Author:  Promega
Download Free Trial Get SnapGene Viewer


SpeI (67) BglII (3007) MluI (2888) BspEI (2675) DrdI (2019) PciI (1911) AgeI (1843) BstBI (1816) AhdI (1741) AsiSI - PvuI - SgfI (104) BtgI - NcoI (107) DraI - PmeI (449) EcoRI (454) Eco53kI (462) BanII - SacI (464) Acc65I (466) AvaI - BsoBI - KpnI - TspMI - XmaI (470) BmeT110I (471) SmaI (472) BamHI (475) XbaI (481) SalI (487) AccI (488) HincII (489) PstI - SbfI (497) SphI (503) BlpI (562) EcoO109I (589) BsaAI - SnaBI (803) SspI (936) EarI (942) XmnI (1141) FspI (1518) BglI (1623) pF1A T7 3455 bp
SpeI  (67)
1 site
A C T A G T T G A T C A
BglII  (3007)
1 site
A G A T C T T C T A G A
MluI  (2888)
1 site
A C G C G T T G C G C A
BspEI  (2675)
1 site
T C C G G A A G G C C T
DrdI  (2019)
1 site
G A C N N N N N N G T C C T G N N N N N N C A G

Sticky ends from different DrdI sites may not be compatible.
PciI  (1911)
1 site
A C A T G T T G T A C A

PciI is inhibited by nonionic detergents.
AgeI  (1843)
1 site
A C C G G T T G G C C A
BstBI  (1816)
1 site
T T C G A A A A G C T T
AhdI  (1741)
1 site
G A C N N N N N G T C C T G N N N N N C A G

The 1-base overhangs produced by AhdI may be hard to ligate.
Sticky ends from different AhdI sites may not be compatible.
AsiSI  (104)
1 site
G C G A T C G C C G C T A G C G
PvuI  (104)
1 site
C G A T C G G C T A G C
SgfI  (104)
1 site
G C G A T C G C C G C T A G C G
BtgI  (107)
1 site
C C R Y G G G G Y R C C

Sticky ends from different BtgI sites may not be compatible.
NcoI  (107)
1 site
C C A T G G G G T A C C
DraI  (449)
1 site
T T T A A A A A A T T T
PmeI  (449)
1 site
G T T T A A A C C A A A T T T G
EcoRI  (454)
1 site
G A A T T C C T T A A G
Eco53kI  (462)
1 site
G A G C T C C T C G A G
BanII  (464)
1 site
G R G C Y C C Y C G R G

Sticky ends from different BanII sites may not be compatible.
SacI  (464)
1 site
G A G C T C C T C G A G
Acc65I  (466)
1 site
G G T A C C C C A T G G
AvaI  (470)
1 site
C Y C G R G G R G C Y C

Sticky ends from different AvaI sites may not be compatible.
BsoBI  (470)
1 site
C Y C G R G G R G C Y C

Sticky ends from different BsoBI sites may not be compatible.
BsoBI is typically used at 37°C, but can be used at temperatures up to 65°C.
KpnI  (470)
1 site
G G T A C C C C A T G G
TspMI  (470)
1 site
C C C G G G G G G C C C
XmaI  (470)
1 site
C C C G G G G G G C C C

Efficient cleavage requires at least two copies of the XmaI recognition sequence.
Full cleavage with XmaI may require a long incubation.
BmeT110I  (471)
1 site
C Y C G R G G R G C Y C
SmaI  (472)
1 site
C C C G G G G G G C C C

SmaI can be used at 37°C for brief incubations.
BamHI  (475)
1 site
G G A T C C C C T A G G

After cleavage, BamHI-HF™ (but not the original BamHI) can remain bound to DNA and alter its electrophoretic mobility.
XbaI  (481)
1 site
T C T A G A A G A T C T
SalI  (487)
1 site
G T C G A C C A G C T G
AccI  (488)
1 site
G T M K A C C A K M T G

Efficient cleavage with AccI requires ≥13 bp on each side of the recognition sequence.
Sticky ends from different AccI sites may not be compatible.
HincII  (489)
1 site
G T Y R A C C A R Y T G
PstI  (497)
1 site
C T G C A G G A C G T C
SbfI  (497)
1 site
C C T G C A G G G G A C G T C C
SphI  (503)
1 site
G C A T G C C G T A C G
BlpI  (562)
1 site
G C T N A G C C G A N T C G

Sticky ends from different BlpI sites may not be compatible.
EcoO109I  (589)
1 site
R G G N C C Y Y C C N G G R

Sticky ends from different EcoO109I sites may not be compatible.
BsaAI  (803)
1 site
Y A C G T R R T G C A Y
SnaBI  (803)
1 site
T A C G T A A T G C A T
SspI  (936)
1 site
A A T A T T T T A T A A
EarI  (942)
1 site
C T C T T C N G A G A A G N N N N

Efficient cleavage requires at least two copies of the EarI recognition sequence.
Sticky ends from different EarI sites may not be compatible.
XmnI  (1141)
1 site
G A A N N N N T T C C T T N N N N A A G
FspI  (1518)
1 site
T G C G C A A C G C G T
BglI  (1623)
1 site
G C C N N N N N G G C C G G N N N N N C C G

Sticky ends from different BglI sites may not be compatible.
AmpR
954 .. 1814  =  861 bp
286 amino acids  =  31.6 kDa
   Segment 1:  signal sequence  
   954 .. 1022  =  69 bp
   23 amino acids  =  2.6 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
AmpR
954 .. 1814  =  861 bp
286 amino acids  =  31.6 kDa
   Segment 2:  
   1023 .. 1814  =  792 bp
   263 amino acids  =  28.9 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
AmpR
954 .. 1814  =  861 bp
286 amino acids  =  31.6 kDa
2 segments
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
ori
1972 .. 2560  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
ori
1972 .. 2560  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
barnase
109 .. 444  =  336 bp
111 amino acids  =  12.5 kDa
Product: ribonuclease from Bacillus amyloliquefaciens
The barnase gene is lethal in standard bacterial transformation strains.
barnase
109 .. 444  =  336 bp
111 amino acids  =  12.5 kDa
Product: ribonuclease from Bacillus amyloliquefaciens
The barnase gene is lethal in standard bacterial transformation strains.
cer region
2676 .. 2959  =  284 bp
ColE1-derived recombination site that helps to maintain plasmids as monomers
cer region
2676 .. 2959  =  284 bp
ColE1-derived recombination site that helps to maintain plasmids as monomers
AmpR promoter
849 .. 953  =  105 bp
AmpR promoter
849 .. 953  =  105 bp
rrnB T1 terminator
3189 .. 3275  =  87 bp
transcription terminator T1 from the E. coli rrnB gene
rrnB T1 terminator
3189 .. 3275  =  87 bp
transcription terminator T1 from the E. coli rrnB gene
T7 terminator
573 .. 620  =  48 bp
transcription terminator for bacteriophage T7 RNA polymerase
T7 terminator
573 .. 620  =  48 bp
transcription terminator for bacteriophage T7 RNA polymerase
rrnB T2 terminator
3367 .. 3394  =  28 bp
transcription terminator T2 from the E. coli rrnB gene
rrnB T2 terminator
3367 .. 3394  =  28 bp
transcription terminator T2 from the E. coli rrnB gene
lac operator
40 .. 64  =  25 bp
The lac repressor binds to the lac operator to inhibit transcription in E. coli. This inhibition can be relieved by adding lactose or isopropyl-β-D-thiogalactopyranoside (IPTG).
lac operator
40 .. 64  =  25 bp
The lac repressor binds to the lac operator to inhibit transcription in E. coli. This inhibition can be relieved by adding lactose or isopropyl-β-D-thiogalactopyranoside (IPTG).
T7 promoter
21 .. 39  =  19 bp
promoter for bacteriophage T7 RNA polymerase
T7 promoter
21 .. 39  =  19 bp
promoter for bacteriophage T7 RNA polymerase
ORF:  109 .. 444  =  336 bp
ORF:  111 amino acids  =  12.5 kDa
ORF:  2921 .. 3268  =  348 bp
ORF:  115 amino acids  =  12.4 kDa
ORF:  954 .. 1814  =  861 bp
ORF:  286 amino acids  =  31.6 kDa
ORF:  3030 .. 3356  =  327 bp
ORF:  108 amino acids  =  12.1 kDa
ORF:  1418 .. 1684  =  267 bp
ORF:  88 amino acids  =  9.2 kDa
Try SnapGene and create your own beautiful maps

Individual Sequences & Maps

SnapGene offers the fastest and easiest way to plan, visualize, and document your molecular biology procedures.

Priced accessibly so that everyone in your lab can have a license.

Learn More...

SnapGene Viewer is a versatile tool for creating and sharing richly annotated sequence files. It opens many common file formats.

Free! Because there should be no barriers to seeing your data.

Learn More...

The map, notes, and annotations on this page and in the sequence/map file are copyrighted material. This material may be used without restriction by academic, nonprofit, and governmental entities, except that the source must be cited as "www.snapgene.com/resources". Commercial entities must contact GSL Biotech LLC for permission and terms of use.

Copyright © 2018 GSL Biotech LLC | Site Map | Privacy | Legal Disclaimers   Subscribe to Our Newsletter